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Abstract: The goal of our study was to measure the kinetics of human colorectal cancer (CRC)
development in order to identify aberrant mechanisms in tissue dynamics and processes that
contribute to colon tumorigenesis. The kinetics of tumor development were investigated using
age-at-tumor diagnosis (adenomas and CRCs) of familial adenomatous coli (FAP) patients and
sporadic CRC patients. Plots of age-at-tumor diagnosis data as a function of age showed a distinct
sigmoidal-shaped curve that is characteristic of an autocatalytic reaction. Consequently, we performed
logistics function analysis and found an excellent fit (p < 0.05) of the logistic equation to the curves
for age-at-tumor diagnoses. These findings indicate that the tissue mechanism that becomes altered
in CRC development and growth involves an autocatalytic reaction. We conjecture that colonic
epithelium normally functions as a polymer of cells which dynamically maintains itself in a steady
state through an autocatalytic polymerization mechanism. Further, in FAP and sporadic CRC patients,
mutation in the adenomatous polyposis coli (APC) gene increases autocatalytic tissue polymerization
and induces tumor tissues to autocatalyze their own progressive growth, which drives tumor
development in the colon.
Keywords: colon cancer; autocatalytic reaction; tissue polymerization; logistic model; nonlinear
function; cancer stem cells; APC gene; familial adenomatous polyposis; crypt fission; tissue renewal
1. Introduction
Colorectal cancer (CRC) is the second leading cause of cancer deaths, with a mortality rate of
~50,000 deaths/year in the US and ~700,000 deaths/year worldwide [1,2]. The scientific community now
widely accepts that CRC develops through an adenoma carcinoma sequence [3,4] and that mutations
in the adenomatous polyposis coli (APC) gene are key driver mutational events in the the initiation
and development of most (>80%) CRCs [5]. APC mutations are acquired in the development of CRC in
sporadic cases and inherited in hereditary CRC cases that occur in the familial adenomatous polyposis
coli (FAP) syndrome. Indeed, investigations of FAP led to the identification, mapping and isolation of
the APC gene. FAP is an autosomal dominant trait caused by inheritance of a germline APC mutation.
Classic FAP patients develop 100s to 1000s of premalignant adenomas which further supports the
Cancers 2020, 12, 460; doi:10.3390/cancers12020460 www.mdpi.com/journal/cancers
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idea that APC mutations drive tumor growth in vivo. If FAP patients are left untreated, they have
nearly a 100% risk of developing CRC. Adenomas in FAP patients show loss of the 2nd wild-type
APC allele [6,7]. Three hits at APC have also been shown to occur in tumors from attenuated FAP
(AFAP) patients who have a milder phenotype with fewer colon polyps (average of 30) and a later age
of colon cancer development [8–10]. Two hits at the APC locus also occur as acquired mutations in
the development of most sporadic CRCs [11]. Additionally, a comprehensive screening of CRC cell
lines and primary CRCs revealed that third hits at APC are acquired in some sporadic tumors [12].
In both FAP and sporadic cases, additional genetic alterations are also acquired during the evolution of
advanced CRC as commonly defined by the “Vogelgram” [13]. While this sequence of genetic and
pathological events in CRC development is well characterized, the kinetics of CRC initiation and
progression have not been fully elucidated.
To investigate the kinetics underlying the CRC development in humans, we studied age-at-tumor
diagnosis (pre-cancerous adenomas and CRC) in both FAP and sporadic patients. While FAP is
relatively uncommon (incidence = 1.90 × 10−6; prevalence = 4.65 × 10−5) [14]), results reported here
should have wider implications for understanding mechanisms involved in the development of
commonly occurring sporadic adenomatous polyps (1 in 2 individuals) and sporadic CRC (1 in 20
individuals) [15]. As noted above, in both FAP and sporadic cases, mutations of APC genes are
known events in the development of colonic tumors [6–12]. Study of the in vivo rate of somatic APC
mutation also supports the theory that FAP and sporadic CRC follow the same genetic pathway [16].
Because a critical part of identification of tumorigenic mechanisms requires testing proposed processes
with quantitative data, a useful mechanistic process for CRC development must provide logical
links between quantitative data and qualitative histopathologic information. Our goal here is to
quantitatively determine the kinetics of adenoma and CRC development in FAP and sporadic cases
in order to identify mechanisms that may explain how changes in tissue dynamics and processes
contribute to CRC development. We selected hereditary and sporadic CRC to investigate because
CRC development progresses in both cases along the lines of normal colon to pre-cancerous colonic
adenomas to CRC, and because data were available from various population studies on FAP and
sporadic patients [17–19].
2. Methods
In our study, we obtained age-at-adenoma and age-at-CRC data from the literature and publicly
available databases [17–19]. The age-at-adenoma diagnosis (n = 293 cases) and age-at-CRC diagnosis
(n = 214 cases) for FAP patients was obtained from the propositus cohort (not the call-up cohort) in the
St Marks Registry and they all had the classical FAP phenotype (100–1000+ polyps) [17]. Classic FAP
patients are known to have germline mutations in APC’s middle region, particularly at codon 1309 [6,7].
The age-at-adenoma diagnosis for sporadic patients (n = 1860) was obtained from the National Polyp
Study [18]. The age-at-colon cancer diagnosis for sporadic CRC patients in the US was obtained from
The Surveillance, Epidemiology, and End Results (SEER) cancer incidence database [19].
To measure kinetics involved in CRC development, we plotted age-at-tumor diagnosis in FAP
patients and sporadic patients as a function of age (Figures 1 and 2). These plots represent the age
distribution for the cohort of patients who develop CRC and the data are extrapolated and normalized
to denote the fraction (0.0 to 1.0) of tumor patients in this cohort based on the range of age-at-tumor
diagnoses as reported in the literature. Inspection of these graphs showed that they are clearly
sigmoidal S-shaped curves. Based on this distinct sigmoidal shape and that S-shaped curves are typical
of autocatalytic reactions [20,21], we surmised that the dynamics of CRC development could involve
an autocatalytic reaction. We do note that S-shaped curves are not proof of an autocatalytic reaction
because they are also characteristic of other processes including growth of populations. Notably,
sigmoid shaped curves also characterize autocatalytic polymerization reactions [22,23] and colonic
epithelia can be viewed as a polymer of colonocytes. Moreover, autocatalysis is a mechanism that
describes self-replication [23,24] and colonic epithelium is a self-replicating system that occurs through
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crypt renewal and crypt fission [25–28]. Thus, we elected to further investigate the possibility of a role
of an autocatalytic mechanism in colonic tumor formation.
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The model has three parameters: γ = 1 (maximum Y-axis value), α = an arbitrary constant, and
k = logistic growth rate or steepness of the curve (slope of rising part of the curve). If k is positive,
the logistic function will increase; if k is negative, the function will decrease.
Curve fitting and statistical analyses were done using Microsoft Excel 2013, Microsoft Office,
Mathematica.exe, Wolfram Research, Inc. and GraphPad Software, Inc., San Diego, CA, USA.
3. Results
Inspection of all the graphs for age-at-tumor diagnosis data (Figures 1 and 2) shows that they
are typical sigmoid-shaped autocatalytic-type reaction curves. All of the graphs have a very similar
S-shaped curve. Both curves for age-at-tumor diagnosis in sporadic CRC patient populations are
right shifted compared to the curves for FAP patient populations. The half-life (t1/2) or inflection
points of age-at-tumor diagnosis plots for FAP adenomas is 17.5 years of age; for FAP CRCs, it is
34 years; for sporadic adenomas, it is 62 years; for sporadic CRCs, it is 68 years. The logistic function
analysis shows an excellent fit (p < 0.05) of the logistic equation to the graphs of age-at-tumor diagnosis
(Figures 3–6, Table 1). While this analysis does not provide proof that the mechanism is autocatalytic,
it does provide compelling evidence for an autocatalytic reaction. Indeed, the S-shape curves of the
logistic function indicate that the growth process proceeds slowly at the start followed by exponential
growth and then by a state in which growth slows and levels off approaching a maximum upper limit.
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Table 1. Summary of the logistic function results.
Tumor α Value k Value Inflection Point (Age)
FAP Adenoma 132 0.29 17.5
FAP CRC 205 0.16 34
Sporadic Adenoma 10656 0.15 62
Sporadic CRC 3335 0.11 68
FAP = familial adenomatous polyposis; CRC = colorectal cancer.
4. Discussion
The main message from this study is that our analysis of the age-at-tumor diagnosis for adenomas
and CRCs in FAP and sporadic patients suggests that the mechanism for colon cancer development and
growth involves an autocatalytic polymerization reaction. The similar shape of the curves indicates
that the mechanism for tumor growth is the same in FAP and sporadic cases, which is consistent
with studies that show that the same types of gene mutations and pathologic changes occur during
the adenoma to CRC development in FAP and sporadic patients. The right shift in the curves for
sporadic cases compared to FAP cases is explained by the fact that in most sporadic tumors, a greater
number of acquired APC mutations occur in sporadic CRCs compared to FAP tumors because FAP
patients have an inherited germline APC mutation. The increased value of the k rate constant for FAP
adenomas (Figure 3, Table 1) suggests that the rate of adenoma growth is accelerated in FAP compared
to sporadic adenomas, which is consistent with the fact that FAP patients develop multiple polyposis
at an early age.
While S-shaped curves are not proof of an autocatalytic mechanism, the goodness of fit with the
logistic function does provide compelling evidence for an autocatalytic reaction. Indeed, the logistic
equation has three parameters so that comparison of the curves involves three characteristics, not
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just one or two measures. Specifically, sigmoid shaped curves can also characterize autocatalytic
polymerization reactions [22,23], which agrees with biology if colonic epithelia are viewed as a polymer
of colonocytes. Moreover, autocatalysis is a mechanism that describes self-replication [23,24] and colonic
epithelium is a self-replicating system that occurs through crypt renewal and crypt fission [25–28].
Further, both crypt renewal and crypt fission rates are increased in FAP epithelium [26,28,31–35].
Assuming that an autocatalytic polymerization reaction contributes to colonic tumor formation, the fact
that the age-at-adenoma diagnosis curves are sigmoid shaped suggests that this putative autocatalytic
reaction occurs early in adenoma morphogenesis. Since the sporadic adenoma curve is right shifted
compared to the FAP adenoma curve and both are S-shaped, this finding suggests that at least two hits
in APC are required for autocatalytic polymerization to increase in colon tumor formation. Given that
these findings suggest the possibility of an autocatalytic mechanism in colonic tumor development
and growth, several points warrant further discussion.
4.1. What Is Known About Autocatalysis and Autocatalytic Polymerization Reactions from Chemistry
and Biology?
Many examples of autocatalytic mechanisms can be found in chemistry and biology. In these
scientific fields, a reaction is said to be autocatalytic if one of the reaction products is also a catalyst
for the same or a coupled reaction. In other words, the reaction product catalyzes its own formation.
The key feature of the corresponding rate equations for autocatalysis is that they describe nonlinear
second order reactions. Examples of autocatalytic reactions in chemistry are found in acid-catalyzed
hydrolyses of esters and other compounds [20]. The classic examples of autocatalysis in biology are
enzymatic reactions and metabolic cycles in glycolysis, particularly phosphofructokinase (PFK) [21].
Such catalytic mechanisms lead to a lowering of the energy of activation of the reaction. Autocatalysis
also occurs in polymerization reaction mechanisms in chemistry and biology.
In some polymer reactions, a polymer can catalyze its own polymerization. For example, in cell
biology, the autocatalytic polymerization kinetics of the cytoskeletal actin network provide a basic
mechanism that explains the persistent random walk of a crawling cell [36]. In tissue biology,
the polymerization-like kinetics of branching morphogenesis provides a basic mechanism that explains
how complex branched epithelial structures in mammalian tissues develop as a self-organized
process [37]. A polymerization reaction involves a process of monomer units reacting together in a
chemical reaction to form polymer chains or three-dimensional networks [38]. Polymerization reactions
involve three dynamic processes, initiation, polymer growth and termination of the polymer. Thus,
polymerization reactions involve depolymerization as well as polymerization processes such as the
dynamics involved in growing and shrinking of microtubules. If we consider colon tissue to be a
polymer of cells, then cells would be the monomers that adhere together to form the tissue polymer
and the extrusion or apoptosis of cells would be the depolymerization process. In this view, tissue
renewal/maintenance could involve a balance between polymerization and depolymerization of cells
and, in this situation, an autocatalytic reaction mechanism contributes to colonic tissue by catalyzing
its own polymerization. If a putative autocatalytic tissue polymerization reaction becomes increased,
this altered state could theoretically contribute to progressive tissue growth and tumor development.
4.2. How Might Gene Mutations that Occur in Colonic Tumors Be Linked to an Autocatalytic
Polymerization Reaction?
As noted above, mutations in the APC gene that occur in the development of CRC are drivers
of tumor growth. In FAP patients, all the cells in their colon will have an APC mutation at birth.
The acquisition of an additional APC mutation(s) appears necessary for adenoma development so the
occurrence of the additional APC alteration is likely a rate limiting step in CRC development. Recent
studies on the big bang model of human colorectal tumor development indicate that tumor tissue
expansion occurs after the initial mutational events in APC. The big bang model was postulated by
Sottoriva et al. [39] based on a study that performed genomic profiling of individual glands from
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different regions within a CRC. This genotyping showed (i) a lack of selective sweeps of genetic
changes, (ii) uniformly high intratumoral heterogeneity and (iii) subclone mixing in the distant regions
of the tumor. The findings revealed that tumors grow predominantly as a single expansion that
produces numerous intermixed subclones that are not subject to stringent selection. In their model,
it is surmised that both public (clonal) and most detectable private (subclonal) alterations arise early
during tumor growth. The profiling of subclones revealed that they wholly retained the original
mutation in APC, which indicates the APC mutation is one of the earliest initiating events that triggers
colon tumorigenesis.
Our results suggesting that an autocatalytic tissue polymerization reaction mechanism contributes
to CRC formation may help clarify how, according to the big bang model, early tumor expansion
happens and produces numerous intermixed subclones. For example, initial inactivation of APC could
increase autocatalytic polymerization of tumor tissues that induces tumors to grow predominantly as a
single expansion. Further, through a process termed epistasis [40], an initial inactivation of APC might
produce numerous intermixed subclones by sensitizing the tumor cell to the proliferative effects of
acquired passenger-type mutations in cells that would otherwise not be affected by these mutations.
In this way interaction between driver and passenger mutations could have non-linear effects leading
to increased proliferation in tumor subclones Thus, theoretically only when an APC driver mutation
occurs in a cell will a passenger mutation have a deleterious effect and the subclone cell populations
will then start to grow rapidly.
Another process that might have a similar effect is the emergence of chromosomal instability in
tumor cells. Indeed, it is known that APC mutations lead to chromosomal instability early in CRC
development which appears to contribute to clonal expansion during evolution of CRC [41]. Thus,
initial inactivating APC events in the colon might lead to an autocatalytic type reaction, epistasis,
and genetic instability that might explain early tumor expansion and emergence of various tumor
subclones as described in the big bang model of CRC development.
4.3. How Might Tissue Changes that Occur in Colonic Tumors Be Tied to an Autocatalytic
Polymerization Reaction?
Colonic tissue changes that lead to adenomas usually only involve the development of 1–3
adenomas in sporadic cases whereas in FAP cases a patient develops hundreds to thousands of adenomas.
Thus, the formation of a large mass of abnormal crypts, i.e., an adenomatous polyp, is accelerated in
FAP compared to sporadic cases. The transformation into adenomas is attributed to an increased rate
of crypt fission which is the biologic mechanism involved in adenoma morphogenesis [28,32,42].
Crypt fission is a process that normally maintains colonic epithelial homeostasis by generating
two identical crypts from one crypt. During human development, as the colon grows in size, crypt
fission is responsible for growth of the epithelium [43]. In adults, the rate of crypt fission equals the
rate of crypt loss in replacement of crypts to maintain a dynamic balance through a process called the
crypt cycle, which is normally controlled by APC [44,45]. However, the rate of crypt fission is increased
in FAP patients due to APC mutation [24,38,41–44]. Thus, an increased rate of crypt fission appears
to be the main cellular mechanism responsible for adenomatous polyp formation and growth. This
mechanism involved in crypt fission appears to resemble an autocatalytic polymerization mechanism
because crypt fission is a process that generates more of the same species—i.e., more crypts. Moreover,
crypts are made up of sheets in interconnected epithelial cells that can be thought of as polymers
of cells. So, crypt fission might be envisioned as a process of polymer branching—a process that
is often found in chemical polymer reactions. Indeed, autocatalysis is a mechanism that describes
self-replication [23,24] and colonic epithelium is a self-replicating system that occurs via crypt renewal
and crypt fission [25–28].
In this view, APC mutation might lead to autocatalytic expansion of crypts and produce a large
mass of crypts, a.k.a. adenoma morphogenesis. Notably, the rate of crypt fission is increased in FAP
patients due to APC mutation [28,42,45–48]. An increased rate of crypt fission appears to be the main
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cellular mechanism responsible for adenomatous polyp formation and growth. Thus, biological data
on crypt fission theoretically support the concept of an autocatalytic tissue polymerization mechanism.
4.4. How Might an Autocatalytic Polymerization Mechanism Help Understand the Stem Cell (SC) Origin of
Colon Cancer?
Currently, the development of CRC is attributed to “overpopulation of cancer stem cells” and
expansion of the so-called “stem cell compartment” [33–35,42,49–54]. We have shown that APC
mutations that drive CRC growth do so by causing SC overpopulation [49]. For example, we discovered
that ALDH1 identifies SCs in normal and malignant colonic tissues and tracks SC overpopulation
during tumor growth in FAP colonic tissues [49]. While APC mutations appear to cause colonic SC
overpopulation and CRC in humans, the cellular mechanism that leads to SC overpopulation is unclear.
Since APC mutations lead to an increase in rate of crypt fissioning and fission of one crypt leads to two
crypts, this process would increase the number of crypt SCs. In this view, crypt fission is tantamount
to symmetric SC division. Consequently, we have proposed that symmetric SC division should be
targeted in future therapeutic approaches in oncology [55,56]. Perhaps an understanding of crypt
fission as an autocatalytic polymerization process might lead to new treatment approaches. Based on
the interpretation of the findings of our study in relation to the biology of CRC, it is conjectured that an
increased rate of autocatalytic tissue polymerization contributes to the cancer SC overpopulation that
drives development and growth of CRC.
5. Conclusions
To identify aberrant mechanisms in tissue dynamics and processes that contribute to colon
tumorigenesis, we investigated age-at-tumor diagnosis (adenomas and CRCs) of familial adenomatous
coli (FAP) patients and sporadic CRC patients. The plots of age-at-tumor diagnosis as a function of
age showed a distinct sigmoidal-shaped curve that characterizes an autocatalytic reaction. Logistics
function analysis showed an excellent fit (p < 0.05) of the logistic equation to the graphs of age-at-tumor
diagnoses. Based on these results, it appears that CRC development occurs through an autocatalytic
tissue polymerization reaction mechanism in both FAP and sporadic tumors. We conjecture that colonic
epithelium normally functions as a polymer of cells which dynamically maintains tissue homeostasis
through an autocatalytic polymerization mechanism. Further, in FAP and sporadic CRC patients, APC
mutations increase autocatalytic tissue polymerization and induce tumor tissues to catalyze their own
progressive growth early in colonic tumor development. Future research into the possibility of this
mechanism may help explain why CRC incidence in the elderly (85+) is decreased [57] and why the
incidence of CRC is increasing in younger (<50) populations [58].
6. Future Directions
Because the autocatalytic tissue polymerization concept presented in this study is still theoretical,
other approaches in future studies are needed. For example, such studies might involve the number of
adenomas developed at different ages and the natural development of polyps/adenomas in one FAP
patient. Moreover, it would be valuable to study other FAP patient cohorts that relate phenotype to the
location of the germline mutation within the APC gene [59]. Other FAP categories include intermediate
and attenuated FAP phenotypes (AFAP). Intermediate FAS patients have a lower polyp phenotype
than classic FAP and most have germline mutations in codon 157–1595, excluding the mutation cluster
region. AFAP patients have an even milder phenotype (<100 polyps) and later onset of both adenomas
and CRC (typically 12 years later compared to classic FAP). Germline mutations in AFAP patients are
in the 5′ part, alternative spliced region in exon 9 or in the extreme 3′ site of APC.
Other hereditary colon cancer syndromes would also be interesting to study such as ones in
which germline mutations lead to an accelerated adenoma–carcinoma progression. Indeed, syndromes
in which germline mutation affects DNA repair, such as Lynch syndrome and MUTH-associated
polyposis, have accelerated tumor development [60,61]. Tumors in Lynch Syndrome have genetic
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instability due to microsatellite instability. This also has relevance to sporadic tumors because most
CRCs are genetically unstable and the instability exists due to two distinct mechanisms—microsatellite
instability (MIN) or chromosomal instability (CIN) [41,62]. MIN exists in a small subset (~15%) of
sporadic CRCs due to aberrant mismatch repair. MIN occurs at the nucleotide level, resulting in
base substitutions and deletions or insertions of a few nucleotides. In most (85%) other sporadic
CRCs, CIN is observed, resulting in gross chromosomal abnormalities such as aneuploidy and loss of
heterozygosity (LOH). APC mutations are the most common initial molecular alterations in the CIN
phenotype [41,62]. Future studies on these various CRC populations with different genetic instabilities
may lead to new insights into how autocatalytic tissue polymerization mechanisms might explain
tumor pathogenesis.
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